Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | IT | Common Stock | Options Exercise | $1.89M | +13.2K | +18.44% | $143.01 | 84.7K | Jul 31, 2024 | Direct | F1 |
transaction | IT | Common Stock | Disposed to Issuer | -$1.89M | -3.77K | -4.44% | $501.19 | 81K | Jul 31, 2024 | Direct | F2 |
transaction | IT | Common Stock | Tax liability | -$2.41M | -4.81K | -5.95% | $501.19 | 76.2K | Jul 31, 2024 | Direct | F3 |
transaction | IT | Common Stock | Options Exercise | $772K | +5K | +6.57% | $154.31 | 81.2K | Jul 31, 2024 | Direct | F1 |
transaction | IT | Common Stock | Disposed to Issuer | -$772K | -1.54K | -1.9% | $501.19 | 79.6K | Jul 31, 2024 | Direct | F2 |
transaction | IT | Common Stock | Tax liability | -$885K | -1.77K | -2.22% | $501.19 | 77.9K | Jul 31, 2024 | Direct | F3 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | IT | Stock Appreciation Rights | Options Exercise | $0 | -13.2K | -100% | $0.00* | 0 | Jul 31, 2024 | Common Stock | 13.2K | $143.01 | Direct | F4 |
transaction | IT | Stock Appreciation Rights | Options Exercise | $0 | -5K | -19.49% | $0.00 | 20.7K | Jul 31, 2024 | Common Stock | 5K | $154.31 | Direct | F5 |
Id | Content |
---|---|
F1 | Represents shares acquired upon exercise of SARs. |
F2 | Represents shares withheld that had an aggregate value, based on the market price on the date of exercise, substantially equal to the aggregate exercise price of the SARs. |
F3 | Represents shares withheld for the payment of applicable income and payroll withholding taxes. |
F4 | These SARs are part of an award that became exercisable in four substantially equal annual installments, commencing on February 6, 2020, and are fully exercisable. |
F5 | These SARs are part of an award that became exercisable in four substantially equal annual installments, commencing on February 5, 2021, and are fully exercisable. |